Abstract
EE704 Risdiplam for the Treatment of Spinal Muscular Atrophy: Impact on the National Healthcare Service During the First 15 Months of Commercialization in Italy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have